Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FST and recently introduced, point-of-care, qualitative rapid diagnostic tests (RDTs) can reliably detect G6PD activities of < 30% activity but they have not been fully validated for detecting heterozygous females having ≥ 30% of normal activity and fail to detect G6PDd with increasing G6PD activity[18,19,20].”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [18]
In the citing paper
“This is consistent with several studies in SE Asia of the FST and G6PD RDTs, demonstrating their high sensitivities in malaria patients [28] and healthy individuals with enzyme activities < 30% activity [18,29] with a spectrum of mostly WHO class II G6PD variants.”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [18]
In the citing paper
“Other studies have reported the mis-diagnosis of G6PD heterozygous females by the FST and G6PD RDTs with declining test sensitivities, as low as ~70%, with G6PD activities between 30—< 60% in G6PDd heterozygous females [18, 28,29,30] and in an in vitro system of G6PD enzyme inhibition of red blood cells [20].”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [18]
In the citing paper
“Although rapid tests that can be used at point-of-care were recently introduced for the diagnosis of G6PDd [58, 59], they may fail to accurately identify individuals with intermediate deficiency (30–80% normal enzymatic activity, mainly heterozygote females) [19].”
In the citing paper
“Current G6PD qualitative rapid tests only diagnose deficiency under the 30% threshold [13–16] and women with intermediate activity are diagnosed as G6PD normal by these tests.”
From Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 1×
“display varying levels of enzyme deficiency due to the partial inactivation of one X chromosome, a phenomenon known as lyonisation [14].”
Background
Research works printed but not linked: 31
- JK Baird, 2012, Reinventing primaquine for endemic malaria, Expert Opin Emerg Drugs, 17, 439, 10.1517/14728214.2012.720252 · DOI
- NJ White, 2012, Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common, Malar J, 11, 418, 10.1186/1475-2875-11-418 · DOI · Paper page
- AS Alving, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report, Bull World Health Organ, 22, 621
- WD Everett, 1977, Hemoglobin E and glucose-6-phosphate deficiency in the Khmer Air Force (Cambodia), Am J Trop Med Hyg, 26, 597, 10.4269/ajtmh.1977.26.597 · doi:10.4269/ajtmh.1977.26.597
- JK Baird, 2004, Primaquine therapy for malaria, Clin Infect Dis, 39, 1336, 10.1086/424663 · DOI · Paper page
- DR Hill, 2006, Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I, Am J Trop Med Hyg, 75, 402, 10.4269/ajtmh.2006.75.402 · DOI · Paper page
- MD Cappellini, 2008, Glucose-6-phosphate dehydrogenase deficiency, Lancet, 371, 64, 10.1016/S0140-6736(08)60073-2 · DOI · Paper page
- AS Alving, 1956, Enzymatic deficiency in primaquine-sensitive erythrocytes, Science, 124, 484, 10.1126/science.124.3220.484-a · DOI · Paper page
- C Louicharoen, 2005, G6PD Viangchan (871G>A) is the most common G6PD-deficient variant in the Cambodian population, J Hum Genet, 50, 448, 10.1007/s10038-005-0276-2 · DOI
- H Matsuoka, 2005, Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population, J Hum Genet, 50, 468, 10.1007/s10038-005-0279-z · DOI
- N Khim, 2013, G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients, Malar J, 12, 171, 10.1186/1475-2875-12-171 · DOI · Paper page
- S Kim, 2011, Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening, PLoS One, 6, e28357, 10.1371/journal.pone.0028357 · DOI · Paper page
- E Beutler, 1962, The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker, Proc Natl Acad Sci U S A, 48, 9, 10.1073/pnas.48.1.9 · DOI · Paper page
- E Beutler, 2008, Glucose-6-phosphate dehydrogenase deficiency: a historical perspective, Blood, 111, 16, 10.1182/blood-2007-04-077412 · DOI · Paper page
- E Beutler, 1994, G6PD deficiency, Blood, 84, 3613, 10.1182/blood.V84.11.3613.bloodjournal84113613 · DOI · Paper page
- GJ Brewer, 1962, The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis, Jama, 180, 386, 10.1001/jama.1962.03050180032008 · doi:10.1001/jama.1962.03050180032008
- RE Bernstein, 1962, A rapid screening dye test for the detection of glucose-6-phosphate dehydrogenase deficiency in red cells, Nature, 194, 192, 10.1038/194192a0 · doi:10.1038/194192a0
- E Beutler, 1968, Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency, Blood, 32, 816, 10.1182/blood.V32.5.816.816 · DOI · Paper page
- E Beutler, 1979, International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, Br J Haematol, 43, 465, 10.1111/j.1365-2141.1979.tb03774.x · DOI · Paper page
- IS Tantular, 2003, An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency, Trop Med Int Health, 8, 569, 10.1046/j.1365-3156.2003.01055.x · DOI
- SA Shekalaghe, 2010, In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals, Antimicrob Agents Chemother, 54, 1762, 10.1128/AAC.01135-09 · DOI
- L von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar J, 12, 112, 10.1186/1475-2875-12-112 · DOI · Paper page
- ER Chan, 2012, Whole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivax, PLoS Negl Trop Dis, 6, e1811, 10.1371/journal.pntd.0001811 · DOI
- G Echler, 1983, Determination of glucose-6-phosphate dehydrogenase levels in red cell preparations, Am J Med Technol, 49, 259
- L Canier, 2013, An innovative tool for moving malaria PCR detection of parasite reservoir into the field, Malar J, 12, 405, 10.1186/1475-2875-12-405 · DOI · Paper page
- GJ Domingo, 2013, G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests, Malar J, 12, 391, 10.1186/1475-2875-12-391 · DOI · Paper page
- S Banoo, 2010, Evaluation of diagnostic tests for infectious diseases: general principles, Nat Rev Microbiol, 8, S17, 10.1038/nrmicro1523z · DOI
- Altman DG (1991) Practical statistics for medical research; Hall. Ca, editor. London. · DOI · Paper page
- TK Chan, 1976, Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency, Br Med J, 2, 1227, 10.1136/bmj.2.6046.1227 · DOI
- RJ Dern, 1955, The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity, J Lab Clin Med, 45, 30
- RE Howes, 2013, G6PD deficiency: global distribution, genetic variants and primaquine therapy, Adv Parasitol, 81, 133, 10.1016/B978-0-12-407826-0.00004-7 · DOI · Paper page
Cited by
Watson, J., Taylor, W. R. J., Bancone, G., Chu, C. S., Jittamala, P., & White, N. J. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006440 · Cited by 77
Self-citationBancone, G., Gornsawun, G., Chu, C. S., Porn, P., Pal, S., Bansil, P., Domingo, G. J., & Nosten, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196716 · Cited by 65
Shitaye, G., Gadisa, E., Grignard, L., Shumie, G., Chali, W., Menberu, T., Belachew, M., Tegegn, G., Challi, S., Curry, J., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2437-8 · Cited by 20
Taylor, W. R. J., Kim, S., Kheng, S., Muth, S., Tor, P., Christophel, E., Mukaka, M., Kerleguer, A., Luzzatto, L., Baird, J. K., et al. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009690 · Cited by 9
Self-citation
Metadata
- Authors
- Roca-Feltrer, A., Khim, N., Kim, S., Chy, S., Canier, L., Kerleguer, A., Tor, P., Chuor, C. M., Kheng, S., Siv, S., Kachur, P. S., Taylor, W. R. J., Hwang, J., & Menard, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-26
- Volume
- 9
- Issue
- 12
- Pages
- e116143
- ISSN
- 1932-6203
- Cited by
- 58
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia. https://app.cochat.ai/papers/10.1371/journal.pone.0116143
- The paper
- Roca-Feltrer, A., Khim, N., Kim, S., Chy, S., Canier, L., Kerleguer, A., Tor, P., Chuor, C. M., Kheng, S., Siv, S., Kachur, P. S., Taylor, W. R. J., Hwang, J., & Menard, D. (2014). Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia. PLoS ONE. https://doi.org/10.1371/journal.pone.0116143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.